Positron Emission Tomography/Computed Tomography with Gallium-68–labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model

Ricardo Alvim,Karan Nagar,Sudeep Das,Souhil Lebdai,Nathan Wong,Alexander Somma,Christopher Hughes,Jasmine Thomas,Sébastien Monette,Avigdor Scherz,Kwanghee Kim,Jan Grimm,Jonathan A Coleman

European Urology Focus（2021）

引用 4|浏览60

暂无评分

摘要

Positron emission tomography/computed tomography with gallium-68–labeled prostate-specific membrane antigen can predict tumor relapse after ablation by vascular-targeted photodynamic therapy earlier than blood prostate-specific antigen levels. This imaging technology may be a useful method to monitor patients with prostate cancer after they receive focal therapy.

查看译文

关键词

Prostate cancer,Vascular-targeted photodynamic therapy,Positron emission tomography/computed tomography with gallium-68–labeled prostate-specific membrane antigen,Focal therapy,Prostate-specific membrane antigen,Prostate ablation,TOOKAD,Positron emission tomography

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要